KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) Invested Capital (2016 - 2025)

Historic Invested Capital for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $86.5 billion.

  • Thermo Fisher Scientific's Invested Capital rose 288.16% to $86.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $86.5 billion, marking a year-over-year increase of 288.16%. This contributed to the annual value of $80.7 billion for FY2024, which is 98.94% down from last year.
  • Thermo Fisher Scientific's Invested Capital amounted to $86.5 billion in Q3 2025, which was up 288.16% from $85.5 billion recorded in Q2 2025.
  • Thermo Fisher Scientific's Invested Capital's 5-year high stood at $86.5 billion during Q3 2025, with a 5-year trough of $53.7 billion in Q2 2021.
  • For the 5-year period, Thermo Fisher Scientific's Invested Capital averaged around $76.0 billion, with its median value being $78.3 billion (2022).
  • As far as peak fluctuations go, Thermo Fisher Scientific's Invested Capital skyrocketed by 3794.02% in 2022, and later crashed by 98.94% in 2024.
  • Thermo Fisher Scientific's Invested Capital (Quarter) stood at $75.5 billion in 2021, then rose by 3.69% to $78.3 billion in 2022, then grew by 4.03% to $81.5 billion in 2023, then decreased by 0.99% to $80.7 billion in 2024, then rose by 7.26% to $86.5 billion in 2025.
  • Its Invested Capital stands at $86.5 billion for Q3 2025, versus $85.5 billion for Q2 2025 and $83.4 billion for Q1 2025.